Bifidobacterium lactis MAK16B42L and Reduced Diastolic Blood Pressure

• Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial

  • 2018-09-27
  • RCT · n = 125
  • International Journal of Obesity 43(9)
  • • A. Pedret
    • R. Valls
    • L. Calderón-Pérez
    • E. Llauradó
    • J. Companys
    • L. Pla-Pagà
    • A. Moragas
    • F. Martín-Luján
    • Y. Ortega
    • M. Giralt
    • A. Caimari
    • E. Chenoll
    • S. Genovés
    • P. Martorell
    • F. Codoñer
    • D. Ramón
    • L. Arola
    • R. Solà

  • PubMed: 30262813
  • DOI: 10.1038/s41366-018-0220-0

  11 Insights on

  • Reduced Diastolic Blood Pressure

  • High evidence
  • Highly Cited
  • Clinical

  Diastolic blood pressure and HOMA index decreased (P < 0.05) after h-k Ba8145.

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes